Discoveries have for the past centuries made lives better. For a long time, diseases have been the biggest threat to human life, killing millions in their wake. Today, cancer is regarded as a global catastrophe, primarily because it so happens to be a silent killer. With many strains of cancer in existence, it has been almost impossible to diagnose and treat the disease. To this end, individuals like Mikhail Blagosklonny have been thinking of better ways of dealing with the ailment. As a University Professor with in-depth knowledge in Internal Medicine, Cardiology, and Experimental Medicine, Blagosklonny has come up with many scientific theories that try to explain different phenomena. However, it is Mikhail’s TOR Signaling theory that has caught the world by surprise.
For years, medical practitioners have considered Rapamycin a drug that can be made use of to suppress pain that comes with cancer. However, Mikhail Blagosklonny, through his TOR Signaling theory tries to explain to the world that Rapamycin can be used to stimulate the growth of stem cells in the body, especially in parts affected by cancer. Additionally, Rapamycin is effective in slowing down the aging process in human beings. Although the theory has not yet undergone serious scrutiny, it seems to hold much ground due to Mikhail Blagosklonny’s outstanding portfolio.
Since 2009, Mikhail has been part and parcel of the Roswell Park Institute where he works as the Professor of Oncology. Before landing a job at the institution, Mikhail was formerly an employee of the New York Medical College as well as the Ordway Research Institute. With an advanced knowledge in disciplines centering on apoptosis, anti-cancer therapeutics, mitosis, ontogenesis, cell cycle, and tumor suppressors, Blagosklonny has been able to play a significant role in the production of the content of PLOS ONE, the American Journal of Pathology. Above all, Mikhail Blagosklonny has contributed significantly to the production of more than 300 articles, concentrating on topics ranging from clinical investigations to molecular biology. His pieces have also paid great focus on Oncology, cell cyclotherpy, and chemotherapeutic engineering.
As a university professor, Mikhail Blagosklonny has achieved significant milestones mainly in the field of medicine. Apart from helping deal with cancer, Mikhail Blagosklonny has made the world have a deeper sense of understanding as to what causes aging. Mikhail acknowledges that by using Rapamycin in the correct amounts, you can deal with the effects of aging. It is because of Mikhail’s findings that medical practitioners across the world now consider Rapamycin as the ‘fountain of youth.’ Rapamycin has been found to be so useful to the extent that it can cure autoimmunity, Alzheimer’s, Osteoporosis, metabolic disorders, and cardiovascular ailments.
Blagosklonny’s discovery comes at a time when the world was almost giving up on cancer. However, we can now see the light at the end of the tunnel, and if future testing proves the TOR Signaling theory to be correct, then many lives will be saved. Above all, suppressing aging will mean that fewer people will suffer from diseases associated with advanced age. Therefore, there is a lot for us to gain from Mikhail’s Tor Signaling theory. View Mikhail’s profile on Google Scholar